Article Details
Retrieved on: 2018-01-05 12:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>The company also plans an <b>initial coin offering</b> and a platform based on blockchain. A Look at Selected Stock Activity. Cellect Biotechnology. Three patients had successful stem-cell transplants using the Israeli company's technology in a midstage trial. Another small trial is planned. The charts record the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here